(Q43686794)
Statements
The influence of CYP2D6 polymorphism on the antiarrhythmic efficacy of propafenone in patients with paroxysmal atrial fibrillation during 3 months propafenone prophylactic treatment (English)
K Orzechowska-Juzwenko
E Jazwinska-Tarnawska
P Niewinski
Z Rzemislawska
K Loboz-Grudzien
M Dmochowska-Perz